Brief: Janone Begins Production Of JAN101 cGMP Batch For Phase 2B PAD Trial & Potential COVID-19 Study

AI Financial

24/09/2020 19:10

Sept 24 (Reuters) - Janone Inc  JAN.O :
    * JANONE SUCCESSFULLY BEGINS PRODUCTION OF JAN101 CGMP BATCH
FOR
PHASE 2B PERIPHERAL ARTERY DISEASE (PAD) TRIAL AND POTENTIAL
COVID-19 STUDY
    * JANONE INC - INITIAL PRODUCTION BATCH WILL BE 250,000
SUSTAINED
RELEASE TABLETS AND MATCHING PLACEBOS
    * JANONE INC - PHASE 2B TRIALS TO TREAT PERIPHERAL ARTERY
DISEASE
IS EXPECTED TO BEGIN IN EARLY 2021

Source text for Eikon:  ID:nPnbM2Tzka 
Further company coverage:  JAN.O 

 ((Reuters.Briefs@thomsonreuters.com;))